Novartis reported CHF56.77B in Equity Capital and Reserves for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Alcon AG ALC:SW 19.09B 29M
Amgen AMGN:US $ 8217M 30M
AstraZeneca AZN:LN 39744M 24068M
Bayer BAYN:GR € 31103M 714M
Biogen BIIB:US $ 10429.9M 322M
Bristol Myers Squibb BMY:US $ 37213M 405M
Eli Lilly And LLY:US $ 7757M 1312.6M
Fresenius FRE:GR € 18301M 602M
Fresenius Medical Care FME:GR € 13446M 1814.05M
Galapagos GLPG:NA € 2617.38M 46.09M
Genmab GEN:DC DK 21285M 1033M
Gilead Sciences GILD:US $ 21471M 1768M
GlaxoSmithKline GSK:LN 15426M 49M
GRIFOLS GRF:SM € 5168.17M 254.92M
H. Lundbeck A/S LUN:DC 18.08B 543M
Hikma Pharmaceutical HIK:LN 2.29B 155M
Lonza Group LONN:SW 7.27B 452M
Merck MRK:GR € 20607M 1314M
Novartis NOVN:VX SF 56771M 2729M
Novartis NVS:US $ 56771M 2729M
Orion ORNBV:FH € 743.1M 44.6M
Philips PHIA:NA € 14561M 2608M
Recordati REC:IM € 1445.07M 116.98M
Regeneron Pharmaceuticals REGN:US $ 17258M 2130.7M